Greater Glasgow and Clyde Medicines

MHRA Drug Safety Update April 2023

In patients weighing up to 150kg, apixaban is the DOAC of choice in NHSGGC for the treatment of venous thromboembolism (VTE) and for stroke prevention secondary to non-valvular AF.

Guideline News March 2023

This month’s Blog highlights a number of issues around how to use the system safely and most effectively.

Part 2 – Safe inpatient prescribing

This blog is the second in a series outlining risks relating to insulin prescribing and administration for adults in hospital, and at discharge and aims to provide good practice points to minimise these risks.

MHRA Drug Safety Update for March 2023

Key Medicine Shortages – March 2023

Part 1 - Medicines Reconciliation (Meds Rec) on admission

This blog is the first in a series outlining risks relating to insulin prescribing and administration for adults in hospital, and at discharge and aims to provide good practice points to minimise these risks.

Errors involving insulin can cause serious harm to patients. Accurate medicines reconciliation is essential to maintain patient safety.